Copyright Reports & Markets. All rights reserved.

Global Blood Transfusion Diagnostics Market Size, Status and Forecast 2019-2025

Request for Sample of this report
Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Blood Transfusion Diagnostics Industry
  • 1.7 COVID-19 Impact: Blood Transfusion Diagnostics Market Trends

    • 2 Global Blood Transfusion Diagnostics Quarterly Market Size Analysis

    • 2.1 Blood Transfusion Diagnostics Business Impact Assessment - COVID-19
      • 2.1.1 Global Blood Transfusion Diagnostics Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Blood Transfusion Diagnostics Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 By Players, Global Blood Transfusion Diagnostics Quarterly Market Size, 2019 VS 2020
    • 3.2 By Players, Blood Transfusion Diagnostics Headquarters and Area Served
    • 3.3 Date of Key Players Enter into Blood Transfusion Diagnostics Market
    • 3.4 Key Players Blood Transfusion Diagnostics Product Offered
    • 3.5 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Blood Transfusion Diagnostics Segments, By Type

    • 4.1 Introduction
      • 1.4.1 ELISA
      • 1.4.2 NAT
      • 1.4.3 Western Blot Assays
      • 1.4.4 Fluorescence Assay
      • 1.4.5 Other Technology
    • 4.2 By Type, Global Blood Transfusion Diagnostics Market Size, 2019-2021

    5 Impact of Covid-19 on Blood Transfusion Diagnostics Segments, By Application

    • 5.1 Overview
      • 5.5.1 Hospitals
      • 5.5.2 Clinics
      • 5.5.3 Blood Banks
      • 5.5.4 Laboratories
      • 5.5.5 Other
    • 5.2 By Application, Global Blood Transfusion Diagnostics Market Size, 2019-2021
      • 5.2.1 By Application, Global Blood Transfusion Diagnostics Market Size by Application, 2019-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Grifols
      • 7.1.1 Grifols Business Overview
      • 7.1.2 Grifols Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.1.3 Grifols Blood Transfusion Diagnostics Product Introduction
      • 7.1.4 Grifols Response to COVID-19 and Related Developments
    • 7.2 Thermo Fisher Scientific
      • 7.2.1 Thermo Fisher Scientific Business Overview
      • 7.2.2 Thermo Fisher Scientific Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.2.3 Thermo Fisher Scientific Blood Transfusion Diagnostics Product Introduction
      • 7.2.4 Thermo Fisher Scientific Response to COVID-19 and Related Developments
    • 7.3 Roche
      • 7.3.1 Roche Business Overview
      • 7.3.2 Roche Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.3.3 Roche Blood Transfusion Diagnostics Product Introduction
      • 7.3.4 Roche Response to COVID-19 and Related Developments
    • 7.4 bioMérieux
      • 7.4.1 bioMérieux Business Overview
      • 7.4.2 bioMérieux Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.4.3 bioMérieux Blood Transfusion Diagnostics Product Introduction
      • 7.4.4 bioMérieux Response to COVID-19 and Related Developments
    • 7.5 Bio-Rad
      • 7.5.1 Bio-Rad Business Overview
      • 7.5.2 Bio-Rad Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.5.3 Bio-Rad Blood Transfusion Diagnostics Product Introduction
      • 7.5.4 Bio-Rad Response to COVID-19 and Related Developments
    • 7.6 Ortho Clinical Diagnostics
      • 7.6.1 Ortho Clinical Diagnostics Business Overview
      • 7.6.2 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.6.3 Ortho Clinical Diagnostics Blood Transfusion Diagnostics Product Introduction
      • 7.6.4 Ortho Clinical Diagnostics Response to COVID-19 and Related Developments
    • 7.7 Becton Dickinson
      • 7.7.1 Becton Dickinson Business Overview
      • 7.7.2 Becton Dickinson Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.7.3 Becton Dickinson Blood Transfusion Diagnostics Product Introduction
      • 7.7.4 Becton Dickinson Response to COVID-19 and Related Developments
    • 7.8 Fujirebio
      • 7.8.1 Fujirebio Business Overview
      • 7.8.2 Fujirebio Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.8.3 Fujirebio Blood Transfusion Diagnostics Product Introduction
      • 7.8.4 Fujirebio Response to COVID-19 and Related Developments
    • 7.9 DiaSorin (American Standard Companies)
      • 7.9.1 DiaSorin (American Standard Companies) Business Overview
      • 7.9.2 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.9.3 DiaSorin (American Standard Companies) Blood Transfusion Diagnostics Product Introduction
      • 7.9.4 DiaSorin (American Standard Companies) Response to COVID-19 and Related Developments
    • 7.10 Beckman Coulter
      • 7.10.1 Beckman Coulter Business Overview
      • 7.10.2 Beckman Coulter Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.10.3 Beckman Coulter Blood Transfusion Diagnostics Product Introduction
      • 7.10.4 Beckman Coulter Response to COVID-19 and Related Developments
    • 7.11 Diagast
      • 7.11.1 Diagast Business Overview
      • 7.11.2 Diagast Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.11.3 Diagast Blood Transfusion Diagnostics Product Introduction
      • 7.11.4 Diagast Response to COVID-19 and Related Developments
    • 7.12 Abbott
      • 7.12.1 Abbott Business Overview
      • 7.12.2 Abbott Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.12.3 Abbott Blood Transfusion Diagnostics Product Introduction
      • 7.12.4 Abbott Response to COVID-19 and Related Developments
    • 7.13 BAG Health Care
      • 7.13.1 BAG Health Care Business Overview
      • 7.13.2 BAG Health Care Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.13.3 BAG Health Care Blood Transfusion Diagnostics Product Introduction
      • 7.13.4 BAG Health Care Response to COVID-19 and Related Developments
    • 7.14 Quidel
      • 7.14.1 Quidel Business Overview
      • 7.14.2 Quidel Blood Transfusion Diagnostics Quarterly Revenue, 2020
      • 7.14.3 Quidel Blood Transfusion Diagnostics Product Introduction
      • 7.14.4 Quidel Response to COVID-19 and Related Developments

    8 Key Findings

      9 Appendix

      • 9.1 About US

      This report covers market size and forecasts of Blood Transfusion Diagnostics, including the following market information:
      Global Blood Transfusion Diagnostics Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Blood Transfusion Diagnostics Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Blood Transfusion Diagnostics Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
      Global Blood Transfusion Diagnostics Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)

      Key market players
      Major competitors identified in this market include Grifols, Thermo Fisher Scientific, Roche, bioMérieux, Bio-Rad, Ortho Clinical Diagnostics, Becton Dickinson, Fujirebio, DiaSorin (American Standard Companies), Beckman Coulter, Diagast, Abbott, BAG Health Care, Quidel, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      ELISA
      NAT
      Western Blot Assays
      Fluorescence Assay
      Other Technology

      Based on the Application:
      Hospitals
      Clinics
      Blood Banks
      Laboratories
      Other

      Buy now